高亲和力自身抗体与1型糖尿病高风险HLA单倍型的关联
研究分析了TrialNet Pathway to Prevention研究中602例至少一种放射结合法糖尿病相关自身抗体阳性的1型糖尿病亲属,探讨高亲和力电化学发光法抗体阳性及水平与高风险HLA单倍型和基因型的关联。结果显示电化学发光法GADA阳性与HLA-DR3和DR4单倍型相关,其水平仅与HLA-DR3相关,电化学发光法IAA阳性与HLA-DR4相关。
要点
- 电化学发光法GADA阳性与HLA-DR3和DR4单倍型相关(均P<0.05)。
- 电化学发光法GADA滴度仅在HLA-DR3单倍型者中较高(均P<0.001)。
- 电化学发光法IAA阳性与HLA-DR4单倍型相关(P<0.05),放射结合法IAA无此关联。
核心结论
- 电化学发光法GADA阳性与HLA-DR3和HLA-DR4单倍型相关,其水平与HLA-DR3单倍型相关。
- 电化学发光法IAA阳性与HLA-DR4单倍型相关。
- 这些研究进一步有助于理解1型糖尿病的遗传风险和胰岛自身免疫内型。
研究设计与样本
- 研究分析了TrialNet Pathway to Prevention研究中602例至少一种放射结合法糖尿病相关自身抗体(GADA或IAA)阳性且有电化学发光法和HLA数据的参与者。
- 电化学发光法和放射结合法抗体水平转换为偏离均值的标准差单位(z分数)进行分析。
主要发现
- 初次访视平均年龄为19.4±13.7岁;344例(57.1%)为女性,104例(17.3%)携带高风险HLA-DR3/4*0302基因型。
- 初次访视时424/602例(70.4%)参与者电化学发光法GADA或IAA阳性,178/602例(29.6%)电化学发光法阴性。
- 电化学发光法和放射结合法GADA阳性与HLA-DR3和DR4单倍型均相关(均P<0.05)。
- 电化学发光法和放射结合法GADA的z分数滴度仅在携带HLA-DR3单倍型的参与者中较高(均P<0.001)。
- 电化学发光法IAA(而非放射结合法IAA)阳性与HLA-DR4单倍型相关(P<0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Electrochemiluminescence (ECL) assays are high-affinity autoantibody (Ab) tests that are more specific than Abs detected by traditional radiobinding assays (RBA) for risk screening and prediction of progression to type 1 diabetes. We sought to characterize the association of high-risk human leukocyte antigen (HLA) haplotypes and genotypes with ECL positivity and levels in relatives of individuals with type 1 diabetes. METHODS: We analyzed 602 participants from the TrialNet Pathway to Prevention Study who were positive for at least 1 RBA diabetes-related Ab [glutamic acid decarboxylase autoantibodies (GADA) or insulin autoantibodies (IAA)] and for whom ECL and HLA data were available. ECL and RBA Ab levels were converted to SD units away from mean (z-scores) for analyses. RESULTS: Mean age at initial visit was 19.4 ± 13.7 years; 344 (57.1%) were female and 104 (17.3%) carried the high-risk HLA-DR3/4*0302 genotype. At initial visit 424/602 (70.4%) participants were positive for either ECL-GADA or ECL-IAA, and 178/602 (29.6%) were ECL negative. ECL and RBA-GADA positivity were associated with both HLA-DR3 and DR4 haplotypes (all Ps < 0.05), while ECL and RBA-GADA z-score titers were higher in participants with HLA-DR3 haplotypes only (both Ps < 0.001). ECL-IAA (but not RBA-IAA) positivity was associated with the HLA-DR4 haplotype (P < 0.05). CONCLUSIONS: ECL-GADA positivity is associated with the HLA-DR3 and HLA-DR4 haplotypes and levels are associated with the HLA-DR3 haplotype. ECL-IAA positivity is associated with HLA-DR4 haplotype. These studies further contribute to the understanding of genetic risk and islet autoimmunity endotypes in type 1 diabetes.
引用
- Triolo TM, Pyle L, Broncucia H, et al. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes. J Clin Endocrinol Metab. 2022. PMID: 34850014. doi:10.1210/clinem/dgab853
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。